Brokerages Set McKesson Co. (NYSE:MCK) PT at $681.00

Shares of McKesson Co. (NYSE:MCK) have received an average rating of “Moderate Buy” from the fifteen analysts that are covering the firm, Marketbeat.com reports. Three investment analysts have rated the stock with a hold recommendation, eleven have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is $683.23.

A number of equities research analysts recently weighed in on MCK shares. Citigroup decreased their price objective on McKesson from $713.00 to $677.00 and set a “buy” rating for the company in a research note on Friday, January 10th. Cfra Research cut McKesson from a “moderate buy” rating to a “hold” rating in a research report on Friday, April 4th. Wells Fargo & Company upped their price target on McKesson from $641.00 to $691.00 and gave the stock an “equal weight” rating in a report on Friday, March 14th. UBS Group upped their target price on McKesson from $708.00 to $805.00 and gave the stock a “buy” rating in a research note on Tuesday, April 29th. Finally, Evercore ISI lifted their price target on shares of McKesson from $650.00 to $675.00 and gave the company an “outperform” rating in a research note on Thursday, February 6th.

Insider Transactions at McKesson

In other McKesson news, CEO Brian S. Tyler sold 8,961 shares of McKesson stock in a transaction that occurred on Friday, February 21st. The shares were sold at an average price of $597.99, for a total value of $5,358,588.39. Following the completion of the sale, the chief executive officer now directly owns 60,664 shares of the company’s stock, valued at approximately $36,276,465.36. The trade was a 12.87 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Leann B. Smith sold 188 shares of the stock in a transaction that occurred on Wednesday, February 12th. The stock was sold at an average price of $609.59, for a total transaction of $114,602.92. Following the sale, the executive vice president now directly owns 1,051 shares of the company’s stock, valued at approximately $640,679.09. This trade represents a 15.17 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 18,110 shares of company stock worth $10,855,706 over the last ninety days. Company insiders own 0.11% of the company’s stock.

Hedge Funds Weigh In On McKesson

Several large investors have recently modified their holdings of MCK. TCTC Holdings LLC raised its stake in shares of McKesson by 25.8% during the first quarter. TCTC Holdings LLC now owns 151 shares of the company’s stock valued at $102,000 after purchasing an additional 31 shares in the last quarter. Meeder Advisory Services Inc. boosted its holdings in shares of McKesson by 3.3% in the first quarter. Meeder Advisory Services Inc. now owns 3,899 shares of the company’s stock valued at $2,624,000 after acquiring an additional 126 shares in the last quarter. JSF Financial LLC bought a new stake in McKesson during the first quarter worth approximately $1,182,000. Pinnacle Wealth Management Advisory Group LLC lifted its position in McKesson by 4.2% in the first quarter. Pinnacle Wealth Management Advisory Group LLC now owns 865 shares of the company’s stock worth $582,000 after purchasing an additional 35 shares during the period. Finally, Fielder Capital Group LLC boosted its stake in McKesson by 14.5% during the 1st quarter. Fielder Capital Group LLC now owns 600 shares of the company’s stock valued at $404,000 after purchasing an additional 76 shares in the last quarter. Institutional investors own 85.07% of the company’s stock.

McKesson Trading Up 1.5 %

MCK stock opened at $721.98 on Thursday. The company has a 50-day moving average price of $676.31 and a 200 day moving average price of $617.52. The stock has a market cap of $90.48 billion, a PE ratio of 33.06, a P/E/G ratio of 1.29 and a beta of 0.53. McKesson has a 12 month low of $464.42 and a 12 month high of $729.40.

McKesson (NYSE:MCK) last issued its earnings results on Wednesday, February 5th. The company reported $8.03 earnings per share for the quarter, missing the consensus estimate of $8.60 by ($0.57). McKesson had a negative return on equity of 181.26% and a net margin of 0.82%. Sell-side analysts forecast that McKesson will post 32.77 EPS for the current year.

McKesson Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, July 1st. Investors of record on Monday, June 2nd will be issued a $0.71 dividend. The ex-dividend date of this dividend is Monday, June 2nd. This represents a $2.84 annualized dividend and a yield of 0.39%. McKesson’s dividend payout ratio (DPR) is presently 13.00%.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.